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Editorial   
Introduction
Indigotindisulfonate (Indigo Carmine, 
American Regent, Shirely, NewYork) is a 
blue dye that is commonly used for 
localizing ureteral orifices during 
surgery[1]. In general, it is considered safe 
and biologically inactive, with the 
manufacturer package insert citing only rare 
idiosyncratic reactions and mild pressor 
effects in some patients[2]. Severe 
reactions from this agent are extremely rare, 
with only 12 published case reports[4-8].  
We report a case of cardiac arrest after an 
intravenous indigotindisulfonate injection 
during a scheduled total abdominal 
hysterectomy with an accompanying 
literature review.  The patient gave written 
consent for authors to publish the 
manuscript.
Case report
A  42-yr-old, 85 kg, 160 
cm, Afro-Caribbean 
female, American Society 
of Anesthesiologists 
physical class II, with a 
past medical history of 
uterine leiomyoma and 
ovarian cysts, was 
scheduled for a total 
abdominal hysterectomy.  
She is allergic to shellfish 
but has no known drug 
allergies.  Patient denied 
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Background: Indigotindisulfonate (Indigo Carmine, American Regent, Shirely, NY) is a blue dye that is 
commonly used for localizing ureteral orifices during surgery. In general, it is safe and biologically inactive, 
with the package insert citing only rare idiosyncratic reactions and mild pressor effects in some patients.  We 
report a case of a severe life-threatening anaphylactoid reaction due to indigotindisulfonate following 
intravenous administration.
Case Report: We describe a case of a 42-year-old female admitted for a total abdominal hysterectomy.  Upon 
arrival to the operating room, her heart rate (HR) was 80/min, blood pressure (BP) was 135/75 mm Hg, 
and a SpO2 of 98%.  During surgery, the patient received 5 mL of slow IV bolus of 0.8 percent 
Indigotindisulfonate sodium injectable solution, at which time her blood pressure was 110/60 mm Hg and 
heart rate was 75/min.  Fifteen minutes later the patient became hypotensive and bradycardic (BP = 70/50 
mm Hg; HR = 37/min).  The team performed advanced cardiac life support for 16 minutes, administering 
epinephrine 1 mg IV BOLUS x 4 doses and sodium bicarbonate 50 mEqIV BOLUS x 3 doses.
Conclusion: Although this is a rare adverse event, it is prudent to consider the possibility of these reactions 
when a bolus of Indigotindisulfonate is administered intravenously.
Keywords: Case report, Indigotindisulfonate Sodium, Indigo Carmine, anaphylactoid, reaction, 
hysterectomy.
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taking prescription, over-the-counter, or 
herbal medications at home.  Her pre-op 
laboratory findings were unremarkable 
(Table 1) and her medications on admission 
included ciprofloxacin, famotidine, 
metoclopramide, metronidazole, and 
tramadol (Table 2).  She denied tobacco, 
alcohol, and recreational drug use.  To her 
knowledge, she had no previous exposure to 
Indigotindisulfate.  
Upon arrival to the operating room, her HR 
was 80/min, BP 135/75 mm Hg, and a 
SpO2 of 98%.  At 11:30am sedation was 
initiated using 4 mg of midazolam IV bolus, 
100 mcg of fentanyl IV BOLUS, 20 mg of 
propofol IV BOLUS, and inhaled isoflurane 
1.5%-3% with oxygen.  After these agents 
were given her vital signs did not change 
significantly.  She received 2 g cefoxitin 
IVPB for surgical prophylaxis.  A second 
dose of 100 mcg IV bolus of fentanyl was 
administered 45 minutes later.  The patient's 
vital signs remained stable for the next 2 
hours (HR = 60-100/min; SBP = 110-150 
mm Hg; DBP = 60-80 mm Hg).  At 1:15pm 
the patient received 5 mL of 0.8% 
Indigotindisulfonate ion via slonjectable 
solutiw IV bolus over 2 minutes, at which 
time her BP was 110/60 mm 
Hg and HR 75/min.  Fifteen 
minutes later the patient 
became hypotensive, SpO2 
97% and the EKG showed 
sinus bradycardia (BP = 70/50 
of mm Hg; HR = 37/min).  
Despite administering 
atropine 0.5mg IV BOLUS x2 
doses, the patient progressed 
to pulseless asystole. The team 
performed the asystole ACLS 
algorithm, initiating chest 
compressions, administering 
epinephrine 1mg IV BOLUS x 
4 doses and sodium bicarbonate 50 mEqIV 
BOLUS x 3 doses with ROSC at 16 minutes.  
Once the patient was 
stabilized she 
received 500mL of 
0.9% sodium 
chloride and 2 units 
of packed  red blood 
cells.  Afterwards the 
procedure was 
completed without 
any other events.  
During the 
procedure the 
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Table 1: Preoperative Lab findings of the case
Table 2: Medications Ordered on Admission
Table 3: Laboratory Findings (Post-Op)
Figure 1:Indigotindisulfonate's structural similarity to 2 molecules of serotonin as if one is a 
mirror image of another.  Serotonin's activity on peripheral vascular resistance may result in a 
reflex bradycardia due to activation of circulatory baroreceptors.This may explain the drop in 
heart rate observed after administration of Indigotindisulfonate in our patient case.
Glu: 143 mg/dL WBC: 10.4 x 103/mm3 CO2: 20 mEq/dL T. bili: 0.7 mg/dL
BUN: 7 mg/dL Neu: 77.6% Ca: 6.5 mg/dL Hgb: 14.8 g/dL
SCr: 0.7 mg/dL Lymph: 18.7% Alb: 1.9 g/dL Hct: 46%
Na: 143 mEq/L Mono: 2.4% AST: 187 U/L  PT: 16.7 sec
K: 3.3 mEq/L Eosin: 1.1% ALT: 89 U/L PTT: >277 sec 
Cl: 112 mEq/L Baso: 0.2% Alk phos: 25 U/L INR: 1.58 
Medication Name Dose Route Frequency
Ciprofloxacin (Cipro®) 500 mg PO Daily
Famotidine (Pepcid®) 20 mg PO Daily
Metoclopramide (Reglan®) 10 mg PO Every 12 hours
Metronidazole (Flagyl®) 500 mg PO Every 8 hours
Tramadol (Ultram®) 50 mg PO Every 12 hours
 Glu: 179 
mg/dL 
 WBC: 10.5 
x 103/mm3 
 CO2: 20 
mEq/dL 
 T. bili: 0.2 
mg/dL 
 BUN: 7 
mg/dL 
 Neu: 65.7% 
 Ca: 8.9 
mg/dL 
 Hgb: 10.4 
g/dL 
 SCr: 0.9 
mg/dL 
 Lymph: 
27.9% 
 Alb: 3.5 
g/dL 
 Hct: 32% 
 Na: 136 
mEq/L 
 Mono: 
5.0% 
 AST: 16 U/L  
 PT: 10.6 
sec 
 K: 4.2 
mEq/L  
 Eosin: 
0.9% 
 ALT: 17 U/L  
 PTT: 20.5 
sec 
 Cl: 110 
mEq/L 
 Baso: 0.4% 
 Alk phos: 
36 U/L 
 INR: 0.9 
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patient also received a total of 2.2 L of 
lactated ringersand suffered an estimated 
blood loss of 300 mL. The patient was later 
transferred to the medical intensive care unit 
in stable condition (BP = 113/75mm Hg, 
HR=62, O2 sat = 99%, RR =12 
breaths/min)(Table 3).
On post-op day 1, the patient was 
successfully extubated and the clinical 
pharmacist attempted to obtain a 
medication and allergy history from the 
patient. However, the patient was not 
oriented enough to provide any reliable or 
coherent information.  She was found to 
have a fever and an elevated white blood cell 
count (WBC) (Table 4).  Chest x-ray 
showed basilar atelectasis and physical exam 
revealed slightly diminished lung sounds.  
On post-op day 2, her WBC and 
temperature both started to decline, and the 
patient was started on vancomycin 1g IV 
piggyback once daily, 
piperacillin/tazobactam 3.375g IV 
piggyback every 6 hours, and levofloxacin 
750mg IV piggyback once daily empirically 
for suspected healthcare associated 
pneumonia.  On post-op day 3, the patient 
was transferred to the internal medicine 
floor, and her WBC and temperature 
continued to resolve.  Her repeat chest X-ray 
was clear, thus antibiotics were 
discontinued.  A second attempt by the 
clinical pharmacist to obtain a medication 
history was made.  This time the patient was 
alert and oriented x 3 and no appreciable 
motor or neuronal deficiencies were noted 
or reported by the patient.  Patient 
reaffirmed that she had no significant drug 
allergies in the past, including over-the-
counter and natural remedies.  Besides 
having a shellfish allergy, she denied any 
food coloring, dyes, or environmental 
allergies.  By post-op day 5 the patient had 
completely recovered and lungs were clear 
bilaterally.  She was discharged home on 
metoprolol 50 mg by mouth twice daily, 
furosemide 20 mg  by mouth daily, losartan 
25 mg by mouth daily, and albuterol MDI 
(90 mcg/puff) 1 puff every 4 hours as 
needed.
Discussion
The most likely agent responsible for this 
patient's hypotension, severe bradycardia, 
and eventual cardiac arrest was the 
Indigotindisulfonate due to the temporal 
relationship between the onset of adverse 
drug event and drug administration. To 
predict the probablility of a true adverse 
drug raction, the NaranjoNomogram was 
used[3]. This nomogram was developed in 
1981 by Naranjo and colleagues to help 
standardize assessment of causality for 
adverse drug reactions.  It consists of 10 
questions answered yes, no, or “do not 
know”.  Different point values for each 
question will give the user a score that will 
be interpreted as doubtful, possible, 
probable, or definite.  The Naranjo 
Nomogram score was 7, indicating probable 
Indigotindisulfonate-induced cardiac arrest.  
Due to the lack of previous exposure or 
allergies to this drug, this was not a 
preventable adverse event.   
Indigotindisulfonate has been widely used 
as an intravenous injection to localize 
ureteral orifices during surgery. It is 
considered safe and efficacious in this 
setting. However, rare cases of serious 
adverse events such as cardiac arrest, 
hypotension, and bradycardia have been 
reported.  Patients often experience a minor 
transient rise in arterial pressures after 
intravenous administration of 
Indigotindisulfonate[4]. Lee and colleagues 
hypothesized that this is likely due to 
Indigotindisulfonate's structural similarity 
to 2 molecules of serotonin, as if one is a 
mirror image of another (Figure 1)[5]. 
Serotonin has been known to increase 
peripheral vascular resistance, which may 
result in a reflex bradycardia due to 
activation of circulatory baroreceptors. This 
may explain the drop in heart rate observed 
after administration of Indigotindisulfonate 
in our patient case. However, this does not 
explain the sharp drop in her blood 
pressure.  Hypovolemia was ruled out as a 
possible cause based on the patient's pre-op 
vital signs, fluids, and electrolytes, as well as 
the relatively minor estimated blood loss 
during the surgery of 300mL.Myocardial 
infarction or ischemia is also unlikely due to 
lack of EKG changes during and after the 
episode.  
Another theory to this Indigotindisulfonate 
induced hypotension and bradycardia is 
possible drug impurities as described in a 
case series by Kim and colleagues[6]. The 
only caveat is that the same manufactured 
lot had been used in other surgeries without 
any additional events.  However, without 
liquid chromatography and mass 
spectrometry, this cannot be completely 
ruled out as a possible cause. Lastly, Shir and 
Raja reported a series of patients that 
experienced severe hypotension during 
radical prostatectomy also citing 
Indigotindisulfonate as the likely cause due 
to the temporal relationship[7].  The 
patients in this case series also received an 
epidural infusion with local anesthetic, and 
Fairley theorized that Indigotindisulfonate 
may induce both stimulant and depressive 
effects[8]. He proposed that the stimulant 
effect may have been dulled by the epidural 
blockade.  However, in our case there was 
no concomitant epidural sympathectomy.
Our prevailing hypothesis to the 
aforementioned adverse effect is an 
anaphylactoid reaction to the dye causing 
the release of histamine or other 
vasodilatory substances. This may explain 
the hypotension observed in our case, 
despite the known mild pressor effects of 
Indigotindisulfonate.  Some may argue that 
the lack of urticaria makes anaphylaxis 
unlikely, but Brady and colleagues noted 
urticaria in only 70% of patients treated for 
anaphylaxis/anaphylactoid reactions[9]. 
Additionally, coronary vasospasms have 
been previously associated with 
anaphylactoid reactions, which may explain 
the reversible myocardial dysfunction[6]. 
Although a diagnosis of anaphylaxis requires 
the evidence more than three organ 
involvement and detection of specific IgE, 
or a positive skin test to the alleged agent, 
these tests were not ordered and therefore 
we are unable to substantiate for these 
findings.
Conclusion
 In conclusion, Indigotindisulfonate is 
arelatively safe and widely utilized dye for 
gynecological procedures.  Due to the 
handful of cases of cardiovascular adverse 
effects reported with its use, albeit rare, 
clinicians must still be diligent in 
monitoring cardiac complications 
associated with it's use. Our case report 
further illustrates that this substance is not 
completely devoid of adverse effects, and 
may even lead to a life threatening event. 
Thus, when cardiac complications arise with 
its use, health care professionals should be 
prepared to manage these severe reactions 
to prevent potentially irreversible ischemic 
harm to the patient.
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